Glenmark gets India approval for favipiravir as Covid-19 treatment - India Today 20-Jun-2020

on

Glenmark gets India approval for favipiravir as Covid-19 treatment - India Today


Glenmark Pharmaceuticals Ltd said on Friday it had received an approval from India's drugs regulator to make and sell oral antiviral drug favipiravir for treating mild-to-moderate Covid-19 patients in the country.

More...